Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
3.
J Womens Health (Larchmt) ; 31(10): 1387-1390, 2022 10.
Article in English | MEDLINE | ID: mdl-36194084
4.
J Womens Health (Larchmt) ; 31(12): 1686-1689, 2022 12.
Article in English | MEDLINE | ID: mdl-34448597

Subject(s)
Affect , Cognition , Female , Humans
6.
J Pediatr Nurs ; 60: 177-180, 2021.
Article in English | MEDLINE | ID: mdl-34216879

ABSTRACT

PURPOSE: Suboptimal vitamin D levels are implicated in low bone mineral density, a common medical complication of anorexia nervosa. This study aimed to examine the frequency of vitamin D assessment and treatment for adolescents with anorexia nervosa in outpatient medical management. DESIGN AND METHODS: Retrospective chart review was used to examine 179 adolescents (M age = 15.5 years, SD = 2.2), newly diagnosed with anorexia nervosa at a tertiary care medical center in the United States between January 2000 and July 2016. RESULTS: Only 16% of patients (n = 29) received serum vitamin D assessments following diagnosis, of whom 52% had suboptimal vitamin D levels (n = 15). Only three patients with suboptimal vitamin D were advised to begin supplementation. No patients in our sample were encouraged to begin prophylactic vitamin D supplementation. CONCLUSIONS/PRACTICE IMPLICATIONS: Findings from this study highlight the critical need for widespread care team education about vitamin D assessment and treatment in the medical management of adolescents with anorexia nervosa, particularly in light of the potentially serious consequences of bone mineral density.


Subject(s)
Anorexia Nervosa , Vitamin D , Adolescent , Anorexia Nervosa/diagnosis , Anorexia Nervosa/therapy , Bone Density , Educational Status , Humans , Retrospective Studies , Vitamin D/therapeutic use
10.
J Dev Behav Pediatr ; 40(2): 92-98, 2019.
Article in English | MEDLINE | ID: mdl-30747833

ABSTRACT

OBJECTIVE: To examine the medical assessment and triage of pediatric patients with anorexia nervosa (AN) initially seen in primary care. METHODS: A retrospective cohort study was conducted for all pediatric patients with AN who had eating/weight concerns and initially identified symptoms in primary care in a single health care system between January 1, 2010, and December 31, 2016. Information on presenting concern, medical assessment/laboratory tests, clinical diagnoses, treatment recommendations, and referrals were abstracted from the medical record. RESULTS: Forty-one (mean age = 13.7 years; SD = 2.2) pediatric patients with AN had eating/weight concerns and initially identified symptoms in a primary care. Overall, only 5% (n = 2/41) of patients received an AN diagnosis during the index visit; a minority were assessed for electrolyte disturbance (n = 20), electrocardiogram abnormality (n = 18), hypothermia (n = 13), binge/purge behaviors (n = 13), orthostatic hypotension (n = 2), or dehydration (n = 1), and only 56% (n = 23) received triage consistent with practice recommendations. Although 61% (n = 25) met criteria for inpatient admission, inpatient hospitalization was recommended for only 2 patients. Patients who received triage consistent with practice recommendations received AN diagnosis and treatment significantly earlier than those who did not (p < 0.01 and p = 0.001, respectively). CONCLUSION: Findings suggest that pediatric patients with AN may not be receiving medical assessment and triage per practice recommendations in the primary care setting. Understanding barriers to evidence-based care for pediatric eating disorders may inform provider education and system-wide changes to enhance outcomes in these patients.


Subject(s)
Anorexia Nervosa/diagnosis , Anorexia Nervosa/therapy , Hospitalization , Primary Health Care , Triage , Adolescent , Child , Female , Guideline Adherence , Hospitalization/statistics & numerical data , Humans , Male , Practice Guidelines as Topic , Primary Health Care/statistics & numerical data , Retrospective Studies , Triage/statistics & numerical data
12.
J Womens Health (Larchmt) ; 26(5): 520-523, 2017 05.
Article in English | MEDLINE | ID: mdl-28388266

ABSTRACT

In this clinical update, we selected recent publications relevant to common neurological concerns in women, with specific attention to stroke, cognition, and headache. We have chosen to highlight articles on sex differences in stroke and stroke treatment, the effect of hormone therapy on stroke risk and on cognition, and symptoms of the migraine postdrome.


Subject(s)
Cognition/physiology , Headache/physiopathology , Headache/psychology , Migraine Disorders/physiopathology , Migraine Disorders/psychology , Stroke , Female , Headache/diagnosis , Humans , Migraine Disorders/diagnosis , Risk Factors , Sex Factors , Stroke/diagnosis , Stroke/therapy
15.
Maturitas ; 94: 46-51, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27823744

ABSTRACT

OBJECTIVES: Bioidentical hormone therapy (BHT) is available in the United States in formulations that have been approved by the Food and Drug Administration (FDA) but also in formulations that have not been so approved. The aim of this study was to evaluate the knowledge, beliefs, and prescribing practices of BHT among healthcare providers. STUDY DESIGN: A cross-sectional self-selected responder survey was conducted of health care providers attending primary care Continuing Medical Education (CME) conferences in the United States from May 2012 to April 2013. The questionnaire consisted of 26 items assessing knowledge, beliefs, and current practice around BHT. RESULTS: A total of 366 survey responses were analyzed. Though 69.8% of respondents accurately identified the definition of BHT, only 45.3% were aware that BHT is available in FDA-approved products and 34.2% of respondents incorrectly identified that BHT is available only in custom-compounded formulations. Of those who had prescribed CC-BHT, less than half agreed with the statement "I am comfortable prescribing BHT" (45.4%). CONCLUSIONS: Our study showed that many practitioners are unaware that bioidentical hormones are available in FDA-approved products. Knowledge gaps identified by this survey highlight the need for and importance of education to further dispel misinformation surrounding the topic.


Subject(s)
Biosimilar Pharmaceuticals/therapeutic use , Health Knowledge, Attitudes, Practice , Hormone Replacement Therapy/methods , Menopause/drug effects , Biosimilar Pharmaceuticals/pharmacology , Cross-Sectional Studies , Female , Health Care Surveys , Humans , United States , United States Food and Drug Administration
16.
Biol Sex Differ ; 7(Suppl 1): 38, 2016.
Article in English | MEDLINE | ID: mdl-27790362

ABSTRACT

BACKGROUND: Addressing healthcare disparities is a national priority for initiatives in precision and individualized medicine. An essential component of precision medicine is the understanding that sex and gender influence health and disease. Whether these issues are addressed in post-graduate medical education curricula is unknown. METHODS: A questionnaire was designed and administered to residents across the Mayo Clinic enterprise to assess current knowledge of sex and gender medicine in a large program of post-graduate medical education and to identify barriers and preferred teaching methods for addressing sex and gender issues in health and disease. Descriptive and qualitative thematic analyses of the survey responses were compiled and analyzed. RESULTS: Responses were collected from 271 residents (response rate 17.2 %; 54 % female; 46 % male). A broad cross-section of training programs on all Mayo Clinic campuses (Arizona, Minnesota, and Florida) was represented. Sixteen percent of the respondents reported they had never had an instructor or preceptor discuss how a patient's sex or gender impacted their care of a patient; 55 % said this happened only occasionally. Of medical knowledge questions about established sex- and gender-related differences, 48 % were answered incorrectly or "unsure." Qualitative thematic analysis showed that many trainees do not understand the potential impact of sex and gender on their clinical practice and/or believe it does not pertain to their specialty. A higher percentage of female participants agreed it was important to consider a patient's sex and gender when providing patient care (60.4 vs. 38.7 %, p = 0.02), and more male than female participants had participated in research that included sex and/or gender as a variable (59.6 vs. 39.0 %, p < 0.01). CONCLUSIONS: Curriculum gaps exist in post-graduate medical training regarding sex- and gender-based medicine, and residents often do not fully understand how these concepts impact their patients' care. Reviewing the definition of sex- and gender-based medicine and integrating these concepts into existing curricula can help close these knowledge gaps. As the practice of medicine becomes more individualized, it is essential to equip physicians with an understanding of how a patient's sex and gender impacts their health to provide the highest value care.

17.
Mayo Clin Proc ; 91(6): 802-7, 2016 06.
Article in English | MEDLINE | ID: mdl-27261868

ABSTRACT

Emergency contraception (EC) may help prevent pregnancy in various circumstances, such as contraceptive method failure, unprotected sexual intercourse, or sexual assault, yet it remains underused. There are 4 approved EC options in the United States. Although ulipristal acetate requires a provider's prescription, oral levonorgestrel (LNG) is available over the counter for women of all ages. The most effective method of EC is the copper intrauterine device, which can be left in place for up to 10 years for efficacious, cost-effective, hormone-free, and convenient long-term primary contraception. Ulipristal acetate tends to be more efficacious in pregnancy prevention than is LNG, especially when taken later than 72 hours postcoitus. The mechanism of action of oral EC is delay of ovulation, and current evidence reveals that it is ineffective postovulation. Women who weigh more than 75 kg or have a body mass index greater than 25 kg/m(2) may have a higher risk of unintended pregnancy when using oral LNG EC; therefore, ulipristal acetate or copper intrauterine devices are preferable in this setting. Providers are often unaware of the range of EC options or are unsure of how to counsel patients regarding the access and use of EC. This article critically reviews current EC literature, summarizes recommendations, and provides guidance for counseling women about EC. Useful tips for health care providers are provided, with a focus on special populations, including breast-feeding women and those transitioning to long-term contraception after EC use. When treating women of reproductive age, clinicians should be prepared to counsel them about EC options, provide EC appropriately, and, if needed, refer for EC in a timely manner.


Subject(s)
Contraception, Postcoital/methods , Health Knowledge, Attitudes, Practice , Intrauterine Devices, Copper , Levonorgestrel , Norpregnadienes , Ovulation/drug effects , Administration, Oral , Attitude of Health Personnel , Body Mass Index , Breast Feeding , Contraception, Postcoital/adverse effects , Contraception, Postcoital/economics , Contraceptive Agents, Female/administration & dosage , Contraceptive Agents, Female/adverse effects , Contraceptive Agents, Female/economics , Contraceptive Agents, Female/supply & distribution , Contraceptives, Postcoital/administration & dosage , Contraceptives, Postcoital/adverse effects , Contraceptives, Postcoital/economics , Contraceptives, Postcoital/supply & distribution , Female , Humans , Intrauterine Devices, Copper/adverse effects , Intrauterine Devices, Copper/economics , Intrauterine Devices, Copper/supply & distribution , Levonorgestrel/administration & dosage , Levonorgestrel/adverse effects , Levonorgestrel/economics , Levonorgestrel/supply & distribution , Nonprescription Drugs/economics , Nonprescription Drugs/standards , Nonprescription Drugs/supply & distribution , Norpregnadienes/administration & dosage , Norpregnadienes/adverse effects , Norpregnadienes/economics , Norpregnadienes/supply & distribution , Patient Education as Topic/methods , Pregnancy , Prescription Drugs/economics , Prescription Drugs/standards
18.
Tex Heart Inst J ; 43(2): 171-4, 2016 Apr.
Article in English | MEDLINE | ID: mdl-27127438

ABSTRACT

Patent foramen ovale is a common clinical finding that generally becomes a concern in the presence of transient ischemic attack or stroke. Rarely, patent foramen ovale is associated with hypoxemia in the presence of substantial right-to-left atrial shunting. We present the case of an 86-year-old woman with a pacemaker, who was initially asymptomatic notwithstanding a patent foramen ovale. Over 1.5 years, her symptoms progressed in a stepwise fashion, in the setting of progressive pacemaker-associated tricuspid regurgitation. Ultimately, the patient's symptoms and her hypoxemia resolved after percutaneous closure of her patent foramen ovale with use of a 25-mm "Cribriform" occluder device. This case highlights the fact that clinically significant right-to-left shunting requires an anatomic lesion, such as patent foramen ovale, together with elevated right atrial pressure, which in this case was contributed by severe tricuspid regurgitation.


Subject(s)
Foramen Ovale, Patent/diagnosis , Heart Atria/diagnostic imaging , Tricuspid Valve Insufficiency/diagnosis , Aged, 80 and over , Cardiac Catheterization , Cardiac Surgical Procedures/methods , Disease Progression , Echocardiography, Doppler, Color , Echocardiography, Transesophageal , Female , Foramen Ovale, Patent/complications , Foramen Ovale, Patent/surgery , Humans , Septal Occluder Device , Tricuspid Valve Insufficiency/complications , Tricuspid Valve Insufficiency/surgery
19.
J Womens Health (Larchmt) ; 25(1): 11-4, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26771560

ABSTRACT

We would like to introduce a new section in the Journal of Women's Health, the Clinical Update. Important studies are continually published in both this Journal and other medical publications. However, it is difficult for busy providers to stay current with the changing literature. The Clinical Update is designed to serve as a review of recently published, high-impact, and potentially practice-changing journal articles, digested for our readers. The Clinical Update will be published on a quarterly basis. Each edition of the update will focus on a specific women's health topic, with planned topics to include menopause, sexual dysfunction, breast health, contraception, osteoporosis, and cardiovascular disease.


Subject(s)
Clinical Studies as Topic , Estrogen Replacement Therapy/adverse effects , Menopause , Research , Women's Health , Estrogen Replacement Therapy/methods , Female , Humans , Menopause/drug effects , Menopause/physiology , Menopause/psychology , Periodicals as Topic/statistics & numerical data , Practice Guidelines as Topic
20.
Clin Res Hepatol Gastroenterol ; 40(2): e15-8, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26066296

ABSTRACT

Anorexia nervosa and other eating disorders characterized by calorie restriction have been associated with a variety of hepatic abnormalities. Fatty steatosis has been described in eating disorder patients. We report the rare finding of glycogen accumulation in the liver in a patient with anorexia nervosa, which to our knowledge is only the second such case reported in the literature. This case highlights the importance of monitoring for liver abnormalities in patients with restrictive eating disorders.


Subject(s)
Anorexia Nervosa/complications , Anorexia Nervosa/metabolism , Liver Diseases/etiology , Liver Glycogen/metabolism , Transaminases/blood , Adult , Anorexia Nervosa/blood , Female , Humans
SELECTION OF CITATIONS
SEARCH DETAIL